178 related articles for article (PubMed ID: 6573879)
1. Indolealkylamine and phenalkylamine hallucinogens. Effect of alpha-methyl and N-methyl substituents on behavioral activity.
Glennon RA; Young R; Jacyno JM
Biochem Pharmacol; 1983 Apr; 32(7):1267-73. PubMed ID: 6573879
[TBL] [Abstract][Full Text] [Related]
2. DOM-stimulus generalization to LSD and other hallucinogenic indolealkylamines.
Glennon RA; Young R; Jacyno JM; Slusher M; Rosecrans JA
Eur J Pharmacol; 1983 Jan; 86(3-4):453-9. PubMed ID: 6572591
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of 2,3-dihydrobenzofuran analogues of the hallucinogen 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane: drug discrimination studies in rats.
Nichols DE; Hoffman AJ; Oberlender RA; Riggs RM
J Med Chem; 1986 Feb; 29(2):302-4. PubMed ID: 3950910
[TBL] [Abstract][Full Text] [Related]
4. Discriminative stimulus properties of DOM and several molecular modifications.
Glennon RA; Young R; Rosecrans JA
Pharmacol Biochem Behav; 1982 Apr; 16(4):553-6. PubMed ID: 7071088
[TBL] [Abstract][Full Text] [Related]
5. Effects of DOM and DMT in a proposed animal model of hallucinogenic activity.
Adams LM; Geyer MA
Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(2):121-32. PubMed ID: 3858911
[TBL] [Abstract][Full Text] [Related]
6. Hallucinogens as a discriminative stimuli: generalization of DOM to a 5-methoxy-N, N-dimethyltryptamine stimulus.
Glennon RA; Rosecrans JA; Young R; Gaines J
Life Sci; 1979 Mar; 24(11):993-7. PubMed ID: 286864
[No Abstract] [Full Text] [Related]
7. A comparison of the behavioral effects of DOM homologs.
Glennon RA; Young R; Rosecrans JA
Pharmacol Biochem Behav; 1982 Apr; 16(4):557-9. PubMed ID: 7071089
[TBL] [Abstract][Full Text] [Related]
8. Choroid plexus epithelial cells in primary culture: a model of 5HT1C receptor activation by hallucinogenic drugs.
Sanders-Bush E; Breeding M
Psychopharmacology (Berl); 1991; 105(3):340-6. PubMed ID: 1665919
[TBL] [Abstract][Full Text] [Related]
9. Behavioral and serotonin receptor properties of 4-substituted derivatives of the hallucinogen 1-(2,5-dimethoxyphenyl)-2-aminopropane.
Glennon RA; Young R; Benington F; Morin RD
J Med Chem; 1982 Oct; 25(10):1163-8. PubMed ID: 7143352
[TBL] [Abstract][Full Text] [Related]
10. MDMA-like stimulus effects of alpha-ethyltryptamine and the alpha-ethyl homolog of DOM.
Glennon RA
Pharmacol Biochem Behav; 1993 Oct; 46(2):459-62. PubMed ID: 7903460
[TBL] [Abstract][Full Text] [Related]
11. Comparison of behavioral properties of di- and tri-methoxyphenylisopropylamines.
Glennon RA; Young R
Pharmacol Biochem Behav; 1982 Oct; 17(4):603-7. PubMed ID: 6965276
[TBL] [Abstract][Full Text] [Related]
12. 1-(2,3-Methylenedioxyphenyl)-2-aminopropane (2,3-MDA): a preliminary investigation.
Glennon RA; Young R; Soine W
Gen Pharmacol; 1984; 15(4):361-2. PubMed ID: 6149169
[TBL] [Abstract][Full Text] [Related]
13. Stimulus properties of 1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDA) analogs.
Glennon RA; Yousif M; Patrick G
Pharmacol Biochem Behav; 1988 Mar; 29(3):443-9. PubMed ID: 2896360
[TBL] [Abstract][Full Text] [Related]
14. A preliminary investigation of the psychoactive agent 4-bromo-2,5-dimethoxyphenethylamine: a potential drug of abuse.
Glennon RA; Titeler M; Lyon RA
Pharmacol Biochem Behav; 1988 Jul; 30(3):597-601. PubMed ID: 3211969
[TBL] [Abstract][Full Text] [Related]
15. Discriminative stimulus properties of MDA analogs.
Glennon RA; Young R; Rosecrans JA; Anderson GM
Biol Psychiatry; 1982 Jul; 17(7):807-14. PubMed ID: 6126227
[TBL] [Abstract][Full Text] [Related]
16. Resolution and absolute configuration of trans-2-(2,5-dimethoxy-4-methylphenyl)cyclopropylamine, a potent hallucinogen analogue.
Nichols DE; Woodard R; Hathaway BA; Lowy MT; Yom KW
J Med Chem; 1979 Apr; 22(4):458-60. PubMed ID: 430485
[TBL] [Abstract][Full Text] [Related]
17. Stereoselective effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane (DOM) on schedule-controlled behavior.
Harris RA; Snell D; Loh HH
Pharmacol Biochem Behav; 1977 Oct; 7(4):307-10. PubMed ID: 928488
[TBL] [Abstract][Full Text] [Related]
18. Indolealkylamine and phenalkylamine hallucinogens: a brief overview.
Glennon RA; Rosecrans JA
Neurosci Biobehav Rev; 1982; 6(4):489-97. PubMed ID: 6757811
[TBL] [Abstract][Full Text] [Related]
19. Hallucinogenic and stimulatory amphetamine derivatives: fingerprinting DOM, DOI, DOB, MDMA, and MBDB by spectral analysis of brain field potentials in the freely moving rat (Tele-Stereo-EEG).
Dimpfel W; Spüler M; Nichols DE
Psychopharmacology (Berl); 1989; 98(3):297-303. PubMed ID: 2568652
[TBL] [Abstract][Full Text] [Related]
20. Behavioral comparisons of R-2-amino-1-(2,5-dimethoxy-4-methylphenyl) butane (BL-3912A) with R-DOM and S-amphetamine.
Tilson HA; Chamberlain JH; Gylys JA
Psychopharmacology (Berl); 1977 Jan; 51(2):169-73. PubMed ID: 402669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
